DexCom Inc (DXCM)

Stay updated with DexCom Inc (DXCM) share price analysis and insights to guide your investment strategy. Stay informed with FP Markets .

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

DexCom Inc (DXCM) Profile

DexCom, Inc. is a medical device business that specializes in the design, development, and marketing of continuous glucose monitoring (CGM) systems in the United States and around the world. The company sells its solutions to persons with diabetes as well as to healthcare practitioners. DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a future generation G7 CGM system; and Dexcom Share, a remote monitoring system, are among its offerings.

DexCom, Inc. is collaborating and licensing next-generation CGM devices with Verily Life Sciences LLC and Verily Ireland Limited. Endocrinologists, physicians, and diabetes educators are the primary customers for the company's goods.

DexCom, Inc. is headquartered in San Diego, California. Full-Time Employees: 5,500. Market Cap 44.811B USD. DexCom total assets for the quarter ending September 30, 2021 were $4.776B, Stock price 462.34-9.15 (-1.94%) At close: 04:00 PM EST DexCom Inc (DXCM.xnas)Analysis.

DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring ('CGM'), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2021, will be approximately $698 million, representing a 23% increase over the fourth quarter of 2020. Revenue in the United States is estimated to be over $517 million, reflecting a 15% increase over the fourth quarter of 2020. International revenue is estimated to be over $181 million, a 54 percent increase over the fourth quarter of 2020. On an organic basis, international growth was around 41%. For fiscal 2021, total preliminary, unaudited revenue is expected to be approximately $2.448 billion, an increase of more than 27% over 2020 on a reported basis and 26%1 on an organic basis.

Start Trading DexCom Inc (DXCM) with a Market Leader Today

DexCom Inc (DXCM) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram